Also, androgen treatment induced prostatic hyperplasia in-vivo is dependent on increased expression of growth factors mainly IGF-1 and IGF-1R21 and increased expression of phosphorylated Akt as well as Bcl-222. The gene discussed is AKT1; the disease is prostate disorder.